IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR INHIXA (ENOXAPARIN BIOSIMILAR)

· London and South East Regional Medicines Information

This UKMi Product Safety assessment on Inhixa (enoxaparin biosimilar) describes the in-use medication safety considerations resultant from the product’s presentation or other pre-defined characteristics. Potential next steps and mitigation actions are suggested. It has been produced using the validated UKMi product assessment tool.

Cardiovascular system disordersEnoxaparinHaematological disordersMedicines SafetyNews

Attachments